相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
Lia Burkhardt et al.
CANCER RESEARCH (2013)
Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes
Michael A. Augello et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss
Yu Chen et al.
NATURE MEDICINE (2013)
The role of EZH2 in tumour progression
C-J Chang et al.
BRITISH JOURNAL OF CANCER (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer
Terence W. Friedlander et al.
CANCER RESEARCH (2012)
Polycomb Protein EZH2 Regulates Tumor Invasion via the Transcriptional Repression of the Metastasis Suppressor RKIP in Breast and Prostate Cancer
Gang Ren et al.
CANCER RESEARCH (2012)
A transcriptional repressor co-regulatory network governing androgen response in prostate cancers
Kern Rei Chng et al.
EMBO JOURNAL (2012)
Cooperation between Polycomb and androgen receptor during oncogenic transformation
Jonathan C. Zhao et al.
GENOME RESEARCH (2012)
Forkhead box A1 (FOXA1) is a key mediator of insulin-like growth factor I (IGF-I) activity
Adam S. Potter et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Integration of Regulatory Networks by NKX3-1 Promotes Androgen-Dependent Prostate Cancer Survival
Peck Yean Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Slug, a Unique Androgen-Regulated Transcription Factor, Coordinates Androgen Receptor to Facilitate Castration Resistance in Prostate Cancer
Kaijie Wu et al.
MOLECULAR ENDOCRINOLOGY (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
Keith F. Decker et al.
NUCLEIC ACIDS RESEARCH (2012)
FOXA1 Promotes Tumor Progression in Prostate Cancer via the Insulin-Like Growth Factor Binding Protein 3 Pathway
Yusuke Imamura et al.
PLOS ONE (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
Changmeng Cai et al.
CANCER CELL (2011)
Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression
Yingming Li et al.
CANCER RESEARCH (2011)
Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
Changmeng Cai et al.
CANCER RESEARCH (2011)
AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription
Si Kee Tan et al.
EMBO JOURNAL (2011)
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Charles E. Massie et al.
EMBO JOURNAL (2011)
Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
Biswajyoti Sahu et al.
EMBO JOURNAL (2011)
Pioneer transcription factors: establishing competence for gene expression
Kenneth S. Zaret et al.
GENES & DEVELOPMENT (2011)
Cyclin D1 Is a Selective Modifier of Androgen-dependent Signaling and Androgen Receptor Function
Clay E. S. Comstock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
Dong Wang et al.
NATURE (2011)
FOXA1 is a key determinant of estrogen receptor function and endocrine response
Antoni Hurtado et al.
NATURE GENETICS (2011)
CENTDIST: discovery of co-associated factors by motif distribution
Zhizhuo Zhang et al.
NUCLEIC ACIDS RESEARCH (2011)
Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
Xiaotun Zhang et al.
PLOS ONE (2011)
TMPRSS2-ERG Gene Fusion Prevalence and Class Are Significantly Different in Prostate Cancer of Caucasian, African-American and Japanese Patients
Cristina Magi-Galluzzi et al.
PROSTATE (2011)
Cyclin D as a therapeutic target in cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2011)
Genomic Analyses of Hormone Signaling and Gene Regulation
Edwin Cheung et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
Raymond J. Andersen et al.
CANCER CELL (2010)
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
Jindan Yu et al.
CANCER CELL (2010)
Molecular cell biology of androgen receptor signalling
Nigel C. Bennett et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines
Modjtaba Emadi Baygi et al.
TUMOR BIOLOGY (2010)
ERG Cooperates with Androgen Receptor in Regulating Trefoil Factor 3 in Prostate Cancer Disease Progression
David S. Rickman et al.
NEOPLASIA (2010)
Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gfene Expression in Castration-Resistant Prostate Cancer
Changmeng Cai et al.
CANCER RESEARCH (2009)
Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven
Gerhardt Attard et al.
CANCER RESEARCH (2009)
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Qianben Wang et al.
CELL (2009)
In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors
Robert Snoek et al.
CLINICAL CANCER RESEARCH (2009)
ChIP-Seq of ERα and RNA polymerase II defines genes differentially responding to ligands
Willem-Jan Welboren et al.
EMBO JOURNAL (2009)
Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers
Harri Makkonen et al.
NUCLEIC ACIDS RESEARCH (2009)
ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells
Yang Zong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
Mathieu Lupien et al.
CELL (2008)
Genome-wide profiling of PPARγ:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis
Ronni Nielsen et al.
GENES & DEVELOPMENT (2008)
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
Gerhardt Attard et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Snail and Slug Promote Epithelial-Mesenchymal Transition through β-Catenin-T-Cell Factor-4-dependent Expression of Transforming Growth Factor-β3
Damian Medici et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and Signaling
Margaret M. Centenera et al.
MOLECULAR ENDOCRINOLOGY (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Q. Cao et al.
ONCOGENE (2008)
Role of the TMPRSS2-ERG gene fusion in prostate cancer
Arul M. Chinnaiyan
NEOPLASIA (2008)
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
Jindan Yu et al.
CANCER RESEARCH (2007)
New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
Charles E. Massie et al.
EMBO REPORTS (2007)
Integrative analysis of genomic aberrations associated with prostate cancer progression
Jung H. Kim et al.
CANCER RESEARCH (2007)
Cell- and gene-specific regulation of primary target genes by the androgen receptor
Eric C. Bolton et al.
GENES & DEVELOPMENT (2007)
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth
Qianben Wang et al.
MOLECULAR CELL (2007)
Identification of novel androgen receptor target genes in prostate cancer
Unnati Jariwala et al.
MOLECULAR CANCER (2007)
Whole-genome cartography of estrogen receptor α binding sites
Chin-Yo Lin et al.
PLOS GENETICS (2007)
Integrative molecular concept modeling of prostate cancer progression
Scott A. Tomlins et al.
NATURE GENETICS (2007)
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation
CJ Burd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1
JS Carroll et al.
CELL (2005)
Global histone modification patterns predict risk of prostate cancer recurrence
DB Seligson et al.
NATURE (2005)
Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer
H Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation
ND Montgomery et al.
CURRENT BIOLOGY (2005)
SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex
R Cao et al.
MOLECULAR CELL (2004)
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
J Holzbeierlein et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity
D Pasini et al.
EMBO JOURNAL (2004)
The role of hepatocyte nuclear factor-3α (forkhead box A1) and androgen receptor in transcriptional regulation of prostatic genes
N Gao et al.
MOLECULAR ENDOCRINOLOGY (2003)
Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex
MC Louie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression
G Verrijdt et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Molecular biology of the androgen receptor
EP Gelmann
JOURNAL OF CLINICAL ONCOLOGY (2002)
Novel ATPase of SNF2-like protein family interacts with androgen receptor and modulates androgen-dependent transcription
N Rouleau et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
Formation of the androgen receptor transcription complex
YF Shang et al.
MOLECULAR CELL (2002)
Contribution of the androgen receptor to prostate cancer predisposition and progression
G Buchanan et al.
CANCER AND METASTASIS REVIEWS (2001)
Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner
AT Reutens et al.
MOLECULAR ENDOCRINOLOGY (2001)
分享论文
